|
Market Closed -
Other stock markets
|
Pre-market 12:11:02 pm | |||
| 43.80 EUR | -3.61% |
|
44.47 | +1.53% |
| 05/03 | Origo Quest Falls 6.3 Percent in February – Increases Holdings in Chemometec and Dynavox | FW |
| 05/03 | Origo Seleqt Down 1.1 Percent in February - Increased Stake in Raysearch | FW |
| Fiscal Period: December | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
Revenues | 151.22Cr | 194.28Cr | 204.96Cr | 172.05Cr | 174.14Cr |
Total Revenues | 151.22Cr | 194.28Cr | 204.96Cr | 172.05Cr | 174.14Cr |
Cost of Goods Sold, Total | 118.9Cr | 155.74Cr | 154.03Cr | 126.8Cr | 128.57Cr |
Gross Profit | 32Cr | 39Cr | 51Cr | 45Cr | 46Cr |
Selling General & Admin Expenses, Total | 19Cr | 20Cr | 22Cr | 20Cr | 19Cr |
R&D Expenses | 5.95Cr | 4.98Cr | 5.43Cr | 5.4Cr | 5.38Cr |
Other Operating Expenses | -1.27Cr | -1.72Cr | -63L | 20L | -46L |
Other Operating Expenses, Total | 24Cr | 23Cr | 26Cr | 25Cr | 23Cr |
Operating Income | 8.65Cr | 16Cr | 25Cr | 20Cr | 22Cr |
Interest Expense, Total | -60L | -62L | -75L | -1.39Cr | -1.27Cr |
Interest And Investment Income | 30L | 56L | 1.52Cr | 1.71Cr | 74L |
Net Interest Expenses | -30L | -6L | 77L | 32L | -53L |
Income (Loss) On Equity Invest. | 63L | 63L | 90L | 46L | -31L |
Currency Exchange Gains (Loss) | 12L | -32L | -26L | -13L | - |
Other Non Operating Income (Expenses) | 0 | 31L | -38L | -38L | -40L |
EBT, Excl. Unusual Items | 9.1Cr | 16Cr | 26Cr | 20Cr | 21Cr |
Restructuring Charges | -55L | -4.19Cr | -12L | - | - |
Merger & Related Restructuring Charges | -79L | -26L | - | - | - |
Gain (Loss) On Sale Of Assets | 24Cr | - | -2L | -2L | 21L |
Other Unusual Items | - | - | -1.32Cr | -2.84Cr | 3L |
EBT, Incl. Unusual Items | 32Cr | 12Cr | 24Cr | 17Cr | 21Cr |
Income Tax Expense | 5.75Cr | 2.49Cr | 4.77Cr | 4.46Cr | 4.78Cr |
Earnings From Continuing Operations | 26Cr | 9.26Cr | 19Cr | 13Cr | 16Cr |
Net Income to Company | 26Cr | 9.26Cr | 19Cr | 13Cr | 16Cr |
Net Income - (IS) | 26Cr | 9.26Cr | 19Cr | 13Cr | 16Cr |
Net Income to Common Incl Extra Items | 26Cr | 9.26Cr | 19Cr | 13Cr | 16Cr |
Net Income to Common Excl. Extra Items | 26Cr | 9.26Cr | 19Cr | 13Cr | 16Cr |
Per Share Items | |||||
Net EPS - Basic | - | - | - | 1.99 | 2.55 |
Basic EPS - Continuing Operations | - | - | - | 1.99 | 2.55 |
Basic Weighted Average Shares Outstanding | - | - | - | 6.43Cr | 6.41Cr |
Net EPS - Diluted | - | - | - | 1.99 | 2.54 |
Diluted EPS - Continuing Operations | - | - | - | 1.99 | 2.54 |
Diluted Weighted Average Shares Outstanding | - | - | - | 6.43Cr | 6.42Cr |
Normalized Basic EPS | - | - | - | 1.96 | 2.03 |
Normalized Diluted EPS | - | - | - | 1.95 | 2.03 |
Dividend Per Share | - | - | - | 1 | 1.1 |
Payout Ratio | 6.73 | 59.61 | 55.42 | 0.16 | 39.19 |
Supplemental Items | |||||
EBITDA | 12Cr | 19Cr | 29Cr | 24Cr | 26Cr |
EBITA | 8.74Cr | 16Cr | 25Cr | 20Cr | 22Cr |
EBIT | 8.65Cr | 16Cr | 25Cr | 20Cr | 22Cr |
Total Revenues (As Reported) | 151.22Cr | 194.28Cr | 204.96Cr | - | - |
Effective Tax Rate - (Ratio) | 18.02 | 21.19 | 19.75 | 25.86 | 22.64 |
Total Current Taxes | 6.07Cr | 3.41Cr | 5Cr | 4.02Cr | 4.24Cr |
Total Deferred Taxes | -38L | -70L | 10L | -17L | 72L |
Normalized Net Income | 5.69Cr | 10Cr | 16Cr | 13Cr | 13Cr |
Interest on Long-Term Debt | 30L | 30L | 31L | 36L | 37L |
Non-Cash Pension Expense | 23L | 25L | - | 24L | - |
Supplemental Operating Expense Items | |||||
Selling and Marketing Expenses | 7.67Cr | 7.92Cr | 8.51Cr | 8.81Cr | 9.19Cr |
General and Administrative Expenses | 11Cr | 12Cr | 13Cr | 11Cr | 9.35Cr |
Research And Development Expense From Footnotes | 5.95Cr | 4.98Cr | 5.43Cr | 5.4Cr | 5.38Cr |
Stock-Based Comp., Other (Total) | 44L | 13L | 39L | 40L | 31L |
Total Stock-Based Compensation | 44L | 13L | 39L | 40L | 31L |
- Stock Market
- Equities
- KALMAR Stock
- Financials Kalmar Oyj
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















